US Patent 11992528 Compositions and methods for conjugating activatable antibodies
Patent 11992528 was granted and assigned to CytomX Therapeutics on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+317 characters)
US Patent 11992528 Compositions and methods for conjugating activatable antibodies
Article
Patent abstract
The invention relates generally to compositions and methods for conjugating antibodies and activatable antibodies, and methods of partially reducing antibodies and/or activatable antibodies prior to conjugation, e.g., thiol-based conjugation, with an agent, e.g., a therapeutic and/or diagnostic agent.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrei William Konradi0
Henry Bernard Lowman0
Luc Roland Desnoyers0
Shweta Singh0
Tony W. Liang0
Date of Patent
May 28, 2024
0Patent Application Number
172270040
Date Filed
April 9, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11992528 Compositions and methods for conjugating activatable antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.